Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows

Condensed Consolidated Statement of Cash Flows - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Cash Flows from Operating Activities:    
Net loss $ 3,469,254 $ (836,857)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of warrant liabilities (4,225,000) (811,667)
Offering costs associated with issuance of warrants 0 275,622
Net gain from investments held in Trust Account (6,933) (13,714)
Changes in operating assets and liabilities:    
Prepaid expenses   (746,931)
Accounts payable—related party   26,176
Accrued expenses   366,547
Net cash used in operating activities   (1,740,824)
Cash Flows from Investing Activities:    
Cash deposited in Trust Account   (275,000,000)
Net cash used in investing activities   (275,000,000)
Cash Flows from Financing Activities:    
Proceeds from note payable to related party   111,835
Repayment of note payable to related party   (111,835)
Proceeds received from initial public offering, gross   275,000,000
Proceeds received from private placement   8,000,000
Offering costs paid   (6,070,576)
Net cash provided by financing activities   276,929,424
Net increase in cash   188,600
Cash—beginning of the period   0
Cash—end of the period $ 188,600 188,600
Supplemental disclosure of noncash activities:    
Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares   25,000
Offering costs included in accrued expenses   85,000
Deferred underwriting commissions   9,625,000
Forfeiture Of Class B Ordinary Shares   $ 2